SCHEMBL8887219

SCHEMBL8887219

C=C(c1ccc(Cl)cc1)c1ccc(CBr)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 2/20 0.45
CES2 O00748 2/20 0.42
CES1 P23141 2/20 0.42
MAOA P21397 2/20 0.41
MAOB P27338 2/20 0.41
MAPT P10636 1/20 0.39
HTT P42858 1/20 0.39
GFER P55789 1/20 0.39
HSD17B10 Q99714 1/20 0.39
GPR55 Q9Y2T6 1/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
ALDH1A1 P00352 1/20 0.39
SLC6A4 P31645 1/20 0.39
IDO1 P14902 1/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
TSHR P16473 2/20 0.37
ALOX15 P16050 1/20 0.37
CYP3A4 P08684 1/20 0.37
MAPK1 P28482 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1796583 0.82 MAPT (0.55) GSK3BCES2CES1MAOAMAOB
SCHEMBL1766 0.82
SCHEMBL8983371 0.81 CES2 (0.64) GSK3BCES2CES1MAOAMAOB
SCHEMBL11026325 0.79 IDO1 (0.50) GSK3BMAOBALDH1A1SLC6A4IDO1
SCHEMBL4358863 0.79 IDO1 (0.50) GSK3BMAOBNPC1RAB9AALDH1A1
SCHEMBL1744667 0.79 SRD5A2 (0.57) GSK3BCES2CES1MAPTNPC1
Benzene SCHEMBL28841146 0.77 TSHR (0.60) GSK3BCES2CES1MAPTALDH1A1
SCHEMBL8885921 0.76 CES2 (0.44) CES2CES1HTTGFERNPC1
SCHEMBL6756387 0.75 MAOB (0.52) GSK3BMAOBALDH1A1SLC6A4IDO1
SCHEMBL10471669 0.73 CNR2 (0.43) HTTRAB9AALDH1A1SLC6A4L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5596020-A Amino bi- and tri-carbocyclic alkane bis-aryl squalene synthase inhibitors RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1997-01-21 US disclosed
US-5561143-A ANTICHOLESTEROL AGENTS, ANTILIPEMIC AGENTS RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1996-10-01 US disclosed
US-5534532-A ANTICHOLESTEROL AGENTS, SQUALENE SYNTHASE INHIBITOR RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1996-07-09 US disclosed
US-5494918-A ANTICHOLESTEROL AGENTS RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1996-02-27 US disclosed
US-5455260-A Anticholesterol agents; reduction of serum cholesterol without reducing mevalonic metabolite synthesis; side effect RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1995-10-03 US disclosed
US-5395846-A Amino Bi- and tri-carbocyclic aklane bis-aryl squalene synthase inhibitors RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1995-03-07 US disclosed
US-5385912-A Hypocholesterolemic or hypolipidemic agents RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1995-01-31 US disclosed
WO-1995000146-A1 AMINO BI- AND TRI-CARBOCYCLIC ALKANE BIS-ARYL SQUALENE SYNTHASE INHIBITORS RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1995-01-05 WO disclosed
WO-1994027601-A1 ALIPHATIC AMINO BIS-ARYL SQUALENE SYNTHASE INHIBITORS RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1994-12-08 WO disclosed
WO-1992015579-A1 MULTICYCLIC TERTIARY AMINE POLYAROMATIC SQUALENE SYNTHETASE INHIBITORS RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) 1992-09-17 WO disclosed